By Samuel Rouleau
Spoon Feed
In a meta-analysis of patients with septic shock, starting norepinephrine earlier had no mortality benefit, though heterogeneity and bias limit clinically relevant conclusions.
These are not the clear-cut answers you’re looking for…
Vasopressors are a crucial component of septic shock management, but figuring out the exact timing to maximize benefit is not well defined. This systematic review and meta-analysis of 12 studies (4 RCTs, 8 observational) explored how the timing of norepinephrine initiation in patients with septic shock impacted mortality and other secondary outcomes. No overall difference in mortality was found between early and late norepinephrine strategies within the RCTs (OR 0.70 95%CI 0.41-1.19) or the observational studies (OR 0.83 95%CI 0.54-1.29). Within the 2 RCTs that did not implement a fluid restriction strategy, there was a mortality benefit when norepinephrine was started earlier (OR 0.49 95%CI 0.25-0.96). Although the RCTs reported a less frequent rate of pulmonary edema in the early norepinephrine group, there was no difference in ventilator-free days, though the 2 observational studies that included this outcome did find an association with early norepinephrine and ventilator free days. This meta-analysis has many limitations. Namely, the actual difference in fluids given within the first 6 hours and 24 hours was not meaningfully different between the early and late groups. Lastly, the time of norepinephrine initiation within the early and late groups is not well standardized, leading to significant room for bias.
How will this change my practice?
There are dangers with both too much fluid and too little fluid. Each patient deserves individualized resuscitation based on their comorbidities and pathophysiology. I tend to start norepinephrine early, but once I start a vasopressor I still fluid resuscitate as indicated.
Source
Comparison of Early and Late Norepinephrine Administration in Patients With Septic Shock: A Systematic Review and Meta-Analysis. Chest. 2024 Dec;166(6):1417-1430. doi: 10.1016/j.chest.2024.05.042. Epub 2024 Jul 5. PMID: 38972348
